부산대학교 도서관

Ghandi M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Huang FW; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; University of California San Francisco, San Francisco, CA, USA.; Jané-Valbuena J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kryukov GV; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Lo CC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; McDonald ER 3rd; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Barretina J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Gelfand ET; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Bielski CM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Li H; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hu K; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Andreev-Drakhlin AY; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Kim J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Hess JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Haas BJ; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Aguet F; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Weir BA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Rothberg MV; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Paolella BR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Lawrence MS; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Akbani R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lu Y; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tiv HL; Belfer Center for Applied Cancer Science, Boston, MA, USA.; Gokhale PC; Belfer Center for Applied Cancer Science, Boston, MA, USA.; de Weck A; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Mansour AA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Oh C; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Shih J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Hadi K; New York Genome Center, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Rosen Y; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Bistline J; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Venkatesan K; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Reddy A; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Sonkin D; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; National Cancer Institute, Rockville, MD, USA.; Liu M; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Lehar J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Korn JM; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Porter DA; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Jones MD; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Golji J; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Caponigro G; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Taylor JE; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Dunning CM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Creech AL; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Warren AC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; McFarland JM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Zamanighomi M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Kauffmann A; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Stransky N; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Imielinski M; New York Genome Center, New York, NY, USA.; Department of Pathology and Laboratory Medicine, Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Maruvka YE; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Cherniack AD; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tsherniak A; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Vazquez F; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Jaffe JD; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Johannessen CM; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Morrissey MP; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Stegmeier F; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Schlegel R; Novartis Institutes for Biomedical Research, Cambridge, MA, USA.; Hahn WC; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Getz G; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mills GB; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Boehm JS; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Golub TR; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Garraway LA; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sellers WR; Novartis Institutes for Biomedical Research, Cambridge, MA, USA. wsellers@broadinstitute.org.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. wsellers@broadinstitute.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Trief PM; Department of Psychiatry & Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.; Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.; Fisher L; Department of Family Medicine, University of California, San Francisco, CA, USA.; Sandberg J; School of Family Life, Brigham Young University, Provo, UT, USA.; Hessler DM; Department of Family Medicine, University of California, San Francisco, CA, USA.; Cibula DA; Department of Public Health & Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.; Weinstock RS; Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.

Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5491 (Electronic) Linking ISSN: 07423071 NLM ISO Abbreviation: Diabet Med Subsets: MEDLINE

Dobrovolsky D; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Wang ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Morrow S; Department of Medical Oncology and.; Leahy C; Department of Medical Oncology and.; Faust T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Donovan KA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Yang G; Department of Medical Oncology and.; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Li Z; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Treon SP; Department of Medical Oncology and.; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA; and.; Weinstock DM; Department of Medical Oncology and.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA.; Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Koch R; Department of Hematology and Medical Oncology, University Medical Center Goettingen, Goettingen, Germany.; Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA.; Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Palmer AC; Harvard Medical School, Boston, MA.; Plana D; Harvard Medical School, Boston, MA.; Shigemori K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Morrow SN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Van Scoyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Wu W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brem EA; Division of Hematology & Oncology, Chao Family Comprehensive Center Center, UC Irvine Health, Orange, CA.; Secrist JP; LifeMine Therapeutics, Cambridge, MA; and.; Drew L; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA.; Schuller AG; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA.; Cidado J; Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, MA.; Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; and.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; and.; Broad Institute of MIT and Harvard, Cambridge, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 100890099 Publication Model: Print Cited Medium: Internet ISSN: 1520-4383 (Electronic) Linking ISSN: 15204383 NLM ISO Abbreviation: Hematology Am Soc Hematol Educ Program Subsets: MEDLINE

Zhou XA; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Louissaint A Jr; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wenzel A; Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Yang J; Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.; Martinez-Escala ME; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Moy AP; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Morgan EA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Paxton CN; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA.; Hong B; Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Andersen EF; Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.; Guitart J; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Behdad A; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Cerroni L; Department of Dermatology, Medical University of Graz, Graz, Austria.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Choi J; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA. Electronic address: jaehyuk.choi@northwestern.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

Hellmuth JC; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY.; Louissaint A Jr; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Szczepanowski M; Department of Pathology, Hematopathology Section and Lymph Node Registry, and.; Department of Internal Medicine II-Hematology, Oncology, Hematology Laboratory, University of Kiel, Kiel, Germany.; Haebe S; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Experimental Leukemia and Lymphoma Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Pastore A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Alig S; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Experimental Leukemia and Lymphoma Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Staiger AM; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology Stuttgart, and University of Tuebingen, Stuttgart, Germany.; Hartmann S; Dr. Senckenberg Institute of Pathology, University Hospital of Frankfurt, Frankfurt am Main, Germany.; Kridel R; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Ducar MD; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA.; Koch P; University Hospital Muenster, Department of Medicine A, Muenster, Germany.; Dreyling M; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Hansmann ML; Dr. Senckenberg Institute of Pathology, University Hospital of Frankfurt, Frankfurt am Main, Germany.; Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.; Rosenwald A; Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Center Mainfranken, Wuerzburg, Germany.; Gascoyne RD; Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.; Hiddemann W; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Experimental Leukemia and Lymphoma Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, and.; Weigert O; Department of Medicine III, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; Experimental Leukemia and Lymphoma Research, University Hospital, Ludwig-Maximilians-University, Munich, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Scarfò I; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Harvard Medical School, Boston, MA.; Ormhøj M; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Department of Clinical Immunology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.; Frigault MJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Harvard Medical School, Boston, MA.; Castano AP; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Lorrey S; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Bouffard AA; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; van Scoyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Shay AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA; and.; Aster JC; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Preffer FI; Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA; and.; Weinstock DM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA.; Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Charlestown, MA.; Harvard Medical School, Boston, MA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood

Layer JV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Cleary JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Brown AJ; School of Molecular Biosciences, Washington State University, Pullman, WA 99164.; Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215.; Morrow SN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Van Scoyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Blasco RB; Department of Pathology, Children's Hospital, Harvard Medical School, Boston, MA.; Karaca E; Department of Pathology, Children's Hospital, Harvard Medical School, Boston, MA.; Meng FL; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02215.; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215.; Department of Genetics, Harvard Medical School, Boston, MA 02215.; Frock RL; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02215.; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215.; Department of Genetics, Harvard Medical School, Boston, MA 02215.; Tivey T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Kim S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Fuchs H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Chiarle R; Department of Pathology, Children's Hospital, Harvard Medical School, Boston, MA.; Department of Molecular Biotechnology and Health Sciences, University of Turin, 10124 Turin, Italy.; Alt FW; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02215.; Program in Cellular and Molecular Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215.; Department of Genetics, Harvard Medical School, Boston, MA 02215.; Roberts SA; School of Molecular Biosciences, Washington State University, Pullman, WA 99164.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; davidm_weinstock@dfci.harvard.edu tovah_day@dfci.harvard.edu.; Broad Institute of MIT and Harvard University, Cambridge, MA 02142.; Day TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; davidm_weinstock@dfci.harvard.edu tovah_day@dfci.harvard.edu.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Cooper ML; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. matthewcooper@wustl.edu.; Choi J; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Staser K; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Department of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Ritchey JK; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Devenport JM; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Eckardt K; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Rettig MP; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Wang B; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Eissenberg LG; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Ghobadi A; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Gehrs LN; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Prior JL; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.; Achilefu S; Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.; Miller CA; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.; Fronick CC; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.; O'Neal J; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Gao F; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Weinstock DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Gutierrez A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, 02215, USA.; Fulton RS; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, 63108, USA.; DiPersio JF; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, 63110, USA. jdipersi@wustl.edu.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE